IS SERUM FIBROBLAST GROWTH FACTOR 21 ASSOCIATED WITH THE SEVERITY OR PRESENCE OF CORONARY ARTERY DISEASE?

Creative Commons License

Nar G., Sanlialp S. C., Nar R., Kilic O., Ozen M. F., GÜNVER M. G., ...More

JOURNAL OF MEDICAL BIOCHEMISTRY, vol.41, no.2, pp.162-167, 2022 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 41 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.5937/jomb0-30191
  • Journal Name: JOURNAL OF MEDICAL BIOCHEMISTRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, Central & Eastern European Academic Source (CEEAS), EMBASE, Veterinary Science Database, Directory of Open Access Journals
  • Page Numbers: pp.162-167
  • Keywords: FGF21, stable angina pectoris, coronary artery disease, ATHEROSCLEROSIS
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University Affiliated: Yes

Abstract

Background: Recent studies have shown that increased circulating concentrations of fibroblast growth factor 21 (FGF21) are associated with obesity, metabolic disorder, and atherosclerosis. However the relationship between FGF21 and coronary artery disease (CAD) is controversial This study was planned to investigate the role of FGF21 in CAD development and CAD severity.